TrialNet's Work to Prevent Type 1 Diabetes: Moving Research Toward Real Options
Researchers at TrialNet and elsewhere are studying ways to prevent or delay Type 1 diabetes onset. Dr. Michael Haller discusses how these prevention studies are progressing and what they might mean for newly diagnosed patients.
Evidence label explains the kind of source behind this article (for example peer-reviewed literature vs community video). It is not medical advice.
Key takeaways
- TrialNet is actively researching prevention strategies for Type 1 diabetes alongside other research groups
- Prevention research represents a shift from current treatments, which have focused on insulin management for nearly a century
- Researchers believe prevention therapies could eventually become a real clinical option, not just a research question
- This work aims to give newly diagnosed patients and at-risk individuals new options beyond current standard care
What TrialNet Does
TrialNet is a research network focused on understanding and preventing Type 1 diabetes. The organization, along with other research groups, is working to develop therapies that could prevent or delay the onset of Type 1 diabetes in at-risk individuals and those newly diagnosed.
A New Approach to Type 1 Diabetes Care
For nearly a century, Type 1 diabetes treatment has centered on insulin replacement. Researchers at TrialNet believe prevention research is moving the field toward an important shift: offering newly diagnosed patients interventions beyond insulin therapy.
According to Dr. Michael Haller, a researcher involved in this work, the field is reaching a point where prevention may transition from purely academic research to practical clinical options for patients.
What This Means for Patients
As prevention research advances, the potential exists to tell newly diagnosed patients about treatment options that could delay or prevent further disease progression. This represents a meaningful expansion of what clinicians can offer beyond current standard care.
These studies are ongoing, and researchers continue to refine and improve prevention approaches. The goal is to make prevention a real therapy available to those at risk or recently diagnosed with Type 1 diabetes.
Evidence label
Source: YouTube community video. Evidence type: Community video — lay discussion, not peer-reviewed research. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.
Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.
Related reading
More evidence-labeled coverage across the Type1Cure library.
- Cure ResearchStem Cell Research Offers New Hope—But Questions RemainCommunity video — lay discussion, not peer-reviewed research
- Cure ResearchWhat Science Now Knows About Beta Cell Regeneration in Type 1 DiabetesCommunity video — lay discussion, not peer-reviewed research
- Cure ResearchWhat We Know About Beta Cell Regeneration Research in DiabetesCommunity video — lay discussion, not peer-reviewed research
- Cure ResearchCan Beta Cells Recover? What Research Shows About Pancreatic Function and Type 2 DiabetesCommunity video — lay discussion, not peer-reviewed research
- Cure ResearchWhat Is the Islet Cell Act? A Guide to Proposed Changes in Transplant RegulationCommunity video — lay discussion, not peer-reviewed research
- Cure ResearchUnderstanding Beta Cell Function in Type 2 Diabetes: What Research ShowsCommunity video — lay discussion, not peer-reviewed research